Form 4: Viemed Healthcare CEO, Casey Hoyt, Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Viemed Healthcare's CEO, Casey Hoyt, reported multiple transactions involving common shares, restricted stock units, and phantom share units.

Summary

  • Casey Hoyt, CEO of Viemed Healthcare, reported several transactions on January 17th and 18th, 2025.
  • These transactions included the vesting of restricted stock units (RSUs) and phantom share units, as well as the withholding of shares to cover tax obligations.
  • On January 17th, 40,068 RSUs vested, and 12,555 shares were withheld for taxes at a price of $8.15 per share.
  • Also on January 17th, 10,017 phantom share units vested, which were settled in cash, and 10,017 shares were disposed of at $8.15 per share.
  • On January 18th, 14,114 phantom share units vested and were settled in cash, with 14,114 shares disposed of at $8.15 per share.
  • Additionally, on January 21st, 2025, 148,791 new RSUs and 37,198 new phantom share units were granted, vesting over three years.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by the CEO, which is neither positive nor negative in itself. It is a neutral event.

Industry Context

This is a standard SEC Form 4 filing, which is common for company insiders reporting transactions in their company's stock. It is a routine part of corporate governance and transparency.

Comparison to Industry Standards

  • The vesting schedules for the RSUs and phantom share units are typical for executive compensation packages.
  • The tax withholding process is standard practice for equity-based compensation.
  • The reporting of these transactions via SEC Form 4 is a mandatory requirement for company insiders.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they represent the vesting of existing equity awards and do not significantly alter the company's capital structure.

Key Dates

DateDescription
01/17/2025Date of multiple transactions including vesting of RSUs and phantom share units, and tax withholding.
01/18/2025Date of phantom share unit vesting and cash settlement.
01/21/2025Date of new RSU and phantom share unit grants.
01/22/2025Date of filing of the SEC Form 4.

Keywords

Viemed Healthcare, Casey Hoyt, stock transactions, restricted stock units, phantom share units, insider trading, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.